174 related articles for article (PubMed ID: 17906611)
1. B-cell lymphoproliferation in chronic inflammatory rheumatic diseases.
Hansen A; Lipsky PE; Dörner T
Nat Clin Pract Rheumatol; 2007 Oct; 3(10):561-9. PubMed ID: 17906611
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype.
Smedby KE; Hjalgrim H; Askling J; Chang ET; Gregersen H; Porwit-MacDonald A; Sundström C; Akerman M; Melbye M; Glimelius B; Adami HO
J Natl Cancer Inst; 2006 Jan; 98(1):51-60. PubMed ID: 16391371
[TBL] [Abstract][Full Text] [Related]
3. The risk of lymphoma development in autoimmune diseases: a meta-analysis.
Zintzaras E; Voulgarelis M; Moutsopoulos HM
Arch Intern Med; 2005 Nov; 165(20):2337-44. PubMed ID: 16287762
[TBL] [Abstract][Full Text] [Related]
4. Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics.
Smedby KE; Baecklund E; Askling J
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2069-77. PubMed ID: 17119030
[TBL] [Abstract][Full Text] [Related]
5. Secondary tumours in Sjögren's syndrome.
Kovács L; Szodoray P; Kiss E
Autoimmun Rev; 2010 Feb; 9(4):203-6. PubMed ID: 19602455
[TBL] [Abstract][Full Text] [Related]
6. B-cell depletion for rheumatic diseases: where are we?
Cohen SB
MedGenMed; 2005 Jun; 7(2):72. PubMed ID: 16369450
[TBL] [Abstract][Full Text] [Related]
7. Expression of APRIL in diffuse large B cell lymphomas from patients with systemic lupus erythematosus and rheumatoid arthritis.
Löfström B; Backlin C; Pettersson T; Lundberg IE; Baecklund E
J Rheumatol; 2011 Sep; 38(9):1891-7. PubMed ID: 21724695
[TBL] [Abstract][Full Text] [Related]
8. B cell depletion therapy in rheumatic disease.
Edwards JC; Cambridge G; Leandro MJ
Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):915-28. PubMed ID: 16980214
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of patients with rheumatic diseases to B-cell non-Hodgkin lymphoma.
Dias C; Isenberg DA
Nat Rev Rheumatol; 2011 Jun; 7(6):360-8. PubMed ID: 21637317
[TBL] [Abstract][Full Text] [Related]
10. Multiple specificities of autoantibodies against hnRNP A/B proteins in systemic rheumatic diseases and hnRNP L as an associated novel autoantigen.
Siapka S; Patrinou-Georgoula M; Vlachoyiannopoulos PG; Guialis A
Autoimmunity; 2007 May; 40(3):223-33. PubMed ID: 17453722
[TBL] [Abstract][Full Text] [Related]
11. Update on Sjögren's syndrome autoimmune epithelitis: from classification to increased neoplasias.
Tzioufas AG; Voulgarelis M
Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):989-1010. PubMed ID: 18068857
[TBL] [Abstract][Full Text] [Related]
12. B cell epitopes of the heterogeneous nuclear ribonucleoprotein A2: identification of a new specific antibody marker for active lupus disease.
Schett G; Dumortier H; Hoefler E; Muller S; Steiner G
Ann Rheum Dis; 2009 May; 68(5):729-35. PubMed ID: 18495733
[TBL] [Abstract][Full Text] [Related]
13. Malignancy and autoimmunity.
Bernatsky S; Ramsey-Goldman R; Clarke A
Curr Opin Rheumatol; 2006 Mar; 18(2):129-34. PubMed ID: 16462517
[TBL] [Abstract][Full Text] [Related]
14. Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjögren's syndrome: correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development.
Manoussakis MN; Boiu S; Korkolopoulou P; Kapsogeorgou EK; Kavantzas N; Ziakas P; Patsouris E; Moutsopoulos HM
Arthritis Rheum; 2007 Dec; 56(12):3977-88. PubMed ID: 18050195
[TBL] [Abstract][Full Text] [Related]
15. Lymphomas in patients with Sjögren's syndrome: review of the literature and physiopathologic hypothesis.
Mariette X
Leuk Lymphoma; 1999 Mar; 33(1-2):93-9. PubMed ID: 10194125
[TBL] [Abstract][Full Text] [Related]
16. Smoking as a trigger for inflammatory rheumatic diseases.
Klareskog L; Padyukov L; Alfredsson L
Curr Opin Rheumatol; 2007 Jan; 19(1):49-54. PubMed ID: 17143096
[TBL] [Abstract][Full Text] [Related]
17. Retrospective study of 82 cases of canine lymphoma in Austria based on the Working Formulation and immunophenotyping.
Guija de Arespacochaga A; Schwendenwein I; Weissenböck H
J Comp Pathol; 2007; 136(2-3):186-92. PubMed ID: 17416237
[TBL] [Abstract][Full Text] [Related]
18. Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus.
Goldblatt F; Isenberg DA
Handb Exp Pharmacol; 2008; (181):163-81. PubMed ID: 18071946
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management.
Peveling-Oberhag J; Arcaini L; Hansmann ML; Zeuzem S
J Hepatol; 2013 Jul; 59(1):169-77. PubMed ID: 23542089
[TBL] [Abstract][Full Text] [Related]
20. Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: are patients with systemic lupus erythematosus at particular risk?
Molloy ES; Calabrese LH
Autoimmun Rev; 2008 Dec; 8(2):144-6. PubMed ID: 18700172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]